We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Careside Validates Manufacturing System

By HospiMedica staff writers
Posted on 31 Jan 2001
Following an independent review of the quality management system for the Careside Analyzer, Careside, Inc. (Culver City, CA, USA) has announced that the system meets ISO 9001 standards and is compliant with U.S. Food and Drug Administration (FDA) requirements. The review was made by Arthur D. Little (ADL), a global management and technology consulting firm.

ADL was retained to review design details of the various technology components of the Analyzer as well as the manufacturing process used by the contract manufacturer. This review resulted in the implementation of design improvements in the manufacturing process of the Analyzer. The review did not include the manufacturing process or product design of the system's test cartridges.

Careside's Analyzer provides an efficient means of measuring blood chemistry, electrochemistry, and coagulation function at the patient's point of care by producing test results within 15 minutes. "While we experienced initial problems common in the manufacturing of complex medical devices, the current manufacturing process is meeting our expectation and consistently producing high-quality and reliable instruments,” said Vickery Stoughton, chairman and CEO of Careside.



Related Links:
Careside Inc

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
HPV Test
Allplex HPV28 Detection
Automated Clinical Chemistry Analyzer
Envoy 500+

Latest Industry News

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers
31 Jan 2001  |   Industry

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada
31 Jan 2001  |   Industry

Natera ctDNA Test to Support Response Monitoring in Solid Tumor Trial
31 Jan 2001  |   Industry